Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Celltrion (068270) Submits FY2024 Audit Report, Reporting Consolidated Revenue of Approximately KRW 3.56T and Receiving ‘Unqualified’ Audit Opinion

Posted on March 17, 2025July 16, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion (068270) Submits FY2024 Audit Report, Reporting Consolidated Revenue of Approximately KRW 3.56T and Receiving ‘Unqualified’ Audit Opinion

Source: Financial Supervisory Service Dart System / 2025-03-17

Disclosure Type: Submission of Audit Report

💡 3-Second Summary

Celltrion has received an unqualified audit opinion from Samil PwC for both its consolidated and separate FY2024 financial statements, reporting consolidated revenue of approximately KRW 3.56T and operating profit of KRW 492B.

📊 1. [Key Disclosure Content & Major Figures Summary]

  • Audit Information:
    • External Auditor: Samil PwC
    • Date of Audit Report Receipt: March 17, 2025
    • Fiscal Period: January 1, 2024 to December 31, 2024
  • Audit Opinions:
    • Consolidated Statements: Unqualified (Appropriate) (Previous FY: Unqualified)
    • Separate Statements: Unqualified (Appropriate) (Previous FY: Unqualified)
    • Going Concern Uncertainty: Not Applicable
    • Internal Control Material Weakness or Non-compliance: Not Applicable
    • Embezzlement/Malfeasance Mentioned in Audit Report: No
  • Key Consolidated Financial & Income Figures:
    • Total Assets: KRW 21,055,222,437,706 (approx. KRW 21.06T) / Previous: KRW 19,956,813,831,274
    • Total Liabilities: KRW 3,475,160,069,015 (approx. KRW 3.48T) / Previous: KRW 2,831,019,524,039
    • Total Equity: KRW 17,580,062,368,691 (approx. KRW 17.58T) / Previous: KRW 17,125,794,307,235
    • Revenue: KRW 3,557,303,554,371 (approx. KRW 3.56T) / Previous: KRW 2,176,431,531,380
    • Operating Profit: KRW 492,015,534,847 (approx. KRW 492B) / Previous: KRW 651,481,422,157
    • Net Profit: KRW 418,883,310,404 (approx. KRW 419B) / Previous: KRW 539,706,505,110
    • Number of Consolidated Subsidiaries: 46 (Previous: 39)
  • Key Separate Financial & Income Figures:
    • Total Assets: KRW 20,241,375,786,274 (approx. KRW 20.24T)
    • Total Liabilities: KRW 2,672,062,493,019 (approx. KRW 2.67T)
    • Total Equity: KRW 17,569,313,293,255 (approx. KRW 17.57T)
    • Revenue: KRW 3,709,213,742,987 (approx. KRW 3.71T) / Previous: KRW 1,873,430,064,117
    • Operating Profit: KRW 1,211,013,945,929 (approx. KRW 1.21T) / Previous: KRW 638,489,472,608
    • Net Profit: KRW 1,004,841,104,456 (approx. KRW 1T) / Previous: KRW 563,268,080,305

📈 2. [Expert Perspective: What This Means for Investors]

  • Audit Opinion Verified: Securing an ‘unqualified’ opinion from the external auditor, Samil PwC, confirms that the financial statements for FY2024 met regulatory accounting standards. No indications of going concern uncertainties or material weaknesses in internal controls were reported.
  • Pre-AGM Unconfirmed Figures: The financial metrics provided in this audit report are preliminary figures submitted prior to the annual general meeting of shareholders. As stated in the disclosure, these figures are subject to change during the official shareholder approval process and should not be treated as finalized.
  • Key Reported Financial Baselines: On a consolidated basis, the reported revenue is approximately KRW 3.56T and the operating profit is approximately KRW 492B, while separate revenue stands at KRW 3.71T and separate operating profit is KRW 1.21T. The total number of consolidated subsidiaries is reported at 46.

📝 Editor’s Comment (by K-STOCK Editor)

Celltrion has disclosed its FY2024 audit report, containing the audited financial statements evaluated by Samil PwC. This filing delivers the accounting data for both consolidated and separate operations to the market prior to the scheduled shareholder decisions.

The immediate check point for investors is the actual approval of these financial statements at the upcoming annual general meeting of shareholders. As highlighted in the regulatory filing, the figures presented in this audit report remain subject to modification during the shareholder approval process, meaning investors must cross-reference these results with the final resolutions approved by shareholders.

Additionally, the number of consolidated subsidiaries has changed to 46, compared to 39 in the previous fiscal year. Investors are advised to utilize the upcoming official annual report to objectively check the finalized financial statements and the breakdown of each financial statement category based on official data.

📢 Disclaimer & Sources

Source: This content was structured and newly generated based on official disclosure data submitted to the Financial Supervisory Service (DART) of South Korea.

Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Inquiries: For compliance queries or copyright requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Jeju Semiconductor (080220) Amends Financials Post-Audit: Net Profit Upgraded to $19.4B KRW with Muscular Balance Sheet Verified
Next Post: [Disclosure] SK Hynix(000660) Finalizes Timeline for Intel NAND Acquisition: Adjusts Closing Date to March 31 to Conclude 5-Year M&A Milestone

Related Posts

[Disclosure] HANMI Semiconductor (042700) Enters US for Citi Global TMT Conference – Declaring Strategic Entry into Nvidia’s CoWoS 2.5D Packaging Market Semiconductors
[Disclosure] Hanwha Ocean (042660) Announces Decision on KRW 700B Debt Guarantee for Tongyeong Eco Power Disclosures
[Disclosure] SK hynix (000660) Reports Blockbuster FY2024 Earnings: Annual Operating Profit Hits KRW 23.4T, Q4 Profit Blows Past KRW 8T! Semiconductors
[Disclosure] Wonik IPS (Ticker: 240810) to Pay KRW 50 Cash Dividend, Building ‘Semiconductor Dream Team’ Board with Ex-Samsung & Hynix Executives Semiconductors
[Disclosure] Hanwha Ocean (042660) Secures KRW 2.5891T Contract from European Shipowner to Construct Seven LNG Carriers Disclosures
[Disclosure] Samsung Biologics (207940) Discloses Additional CMO Contract Worth KRW 56.7B with European Pharmaceutical Company Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme